Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Xtant Medical Holdings, Inc. before investing.

In this article, we go over a few key elements for understanding Xtant Medical Holdings, Inc.’s stock price such as:

• Xtant Medical Holdings, Inc.’s current stock price and volume
• Why Xtant Medical Holdings, Inc.’s stock price changed recently
• Upgrades and downgrades for XTNT from analysts
• XTNT’s stock price momentum as measured by its relative strength

About Xtant Medical Holdings, Inc. (XTNT)

Before we jump into Xtant Medical Holdings, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.

Want to learn more about Xtant Medical Holdings, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Xtant Medical Holdings, Inc..

Xtant Medical Holdings, Inc.’s Stock Price as of Market Close

As of September 03, 2026, 4:00 PM, CST, Xtant Medical Holdings, Inc.’s stock price was $0.396.

Xtant Medical Holdings, Inc. is down 3.28% from its previous closing price of $0.409.

During the last market session, Xtant Medical Holdings, Inc.’s stock traded between $0.380 and $0.420. Currently, there are approximately 140.26 million shares outstanding for Xtant Medical Holdings, Inc..

Xtant Medical Holdings, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Xtant Medical Holdings, Inc. Stock Price History

Xtant Medical Holdings, Inc.’s (XTNT) price is currently up 0.92% so far this month.

During the month of September, Xtant Medical Holdings, Inc.’s stock price has reached a high of $0.440 and a low of $0.356.

Over the last year, Xtant Medical Holdings, Inc. has hit prices as high as $0.950 and as low as $0.270. Year to date, Xtant Medical Holdings, Inc.’s stock is down 49.54%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Xtant Medical Holdings, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 02, 2026, there was 1 analyst who downgraded Xtant Medical Holdings, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Xtant Medical Holdings, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Xtant Medical Holdings, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Xtant Medical Holdings, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Xtant Medical Holdings, Inc. (XTNT) by visiting AAII Stock Evaluator.

Relative Price Strength of Xtant Medical Holdings, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 02, 2026, Xtant Medical Holdings, Inc. has a weighted four-quarter relative price strength of -12.70%, which translates to a Momentum Score of 19 and is considered to be Very Weak.

Want to learn more about how Xtant Medical Holdings, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Xtant Medical Holdings, Inc. Stock Price: Bottom Line

As of September 3, 2026, Xtant Medical Holdings, Inc.’s stock price is $0.396, which is down 3.28% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Xtant Medical Holdings, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.